Company · CIK 0001337223
CytRx Oncology Corp
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/ACytRx Oncology Corp0001144204-09-008869 · 162.8 KBSEC(opens sec.gov)
- 10-K/AInnovive Pharmaceuticals, Inc.0000950123-08-004833 · 210.8 KBSEC(opens sec.gov)
- 4Insider trades0001181431-07-045404 · 8.9 KBSEC(opens sec.gov)
- 4Insider trades0001181431-07-045403 · 9.5 KBSEC(opens sec.gov)
- 8-KCurrent report0000950144-07-006247 · 1.3 MBSEC(opens sec.gov)
- SC 13GInnovive Pharmaceuticals, Inc.0000950135-07-003633 · 83.9 KBSEC(opens sec.gov)
- 8-KCurrent report0000950123-07-008408 · 25.4 KBSEC(opens sec.gov)
- 8-KCurrent report0000950144-07-005451 · 26.2 KBSEC(opens sec.gov)
- 8-KCurrent report0000950123-07-007280 · 13.1 KBSEC(opens sec.gov)
- 8-KCurrent report0000950123-07-005965 · 281.3 KBSEC(opens sec.gov)
Insiders
Tickers
No tickers on record.
Addresses
business
555 MADISON AVENUE, 25TH FLOOR
NEW YORK, NY, 10022
mailing
555 MADISON AVENUE, 25TH FLOOR
NEW YORK, NY, 10022
Former names
- Innovive Pharmaceuticals, Inc.2008-08-14
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies